Core Labs raised at Citi as further negative revision risk seen as minimal
Core Laboratories upgraded at Citi, which says the risk/reward skew for the stock looks more balanced with further negative ...
Seeking Alpha14d
Citi: The Most Compelling Valuation In Banking
I started buying shares in Citi (NYSE:C) back in 2021 when it was trading in the low 70s, in my young investor's mind, I could not understand why this bank was trading 20% lower than its book value.
Investing.com South Africa14d
Bath & Body Works raised at Citi as ’sales/margin inflection in progress’
Citi expects first-quarter trends to outperform expectations. “We believe 1QTD trends are running above 1Q guidance, and ...